2006 ICD-9-CM Volume 1 Diagnosis Codes Home > Certain Conditions Originating In The Perinatal Period 760-779 > Maternal Causes Of Perinatal Morbidity And Mortality 760-763 > Fetus Or Newborn Affected By Maternal Conditions Which May Be Unrelated To Present Pregnancy 760.* > 2006 ICD-9-CM Diagnosis 760.78 Antimetabolic agents View the most recent version of ICD-9-CM 760.78 760.78 is a specific code that can be used to specify a diagnosis 760.78 contains 22 index entries View the ICD-9-CM Volume 1 760.* hierarchy Alternate Terminology Methotrexate Retinoic acid Statins  Index entries containing 760.78: Absorption antimetabolics, through placenta or breast milk 760.78 chemical NEC 989.9 through placenta or breast milk (fetus or newborn) 760.70 antimetabolics 760.78 drug NEC (see also Reaction, drug) through placenta or breast milk (fetus or newborn) 760.70 antimetabolics 760.78 Intoxication chemical - see also Table of Drugs and Chemicals via placenta or breast milk 760.70 antimetabolics 760.78 drug 292.89 via placenta or breast milk 760.70 antimetabolics 760.78 fetus or newborn, via placenta or breast milk 760.70 antimetabolics 760.78 Maternal condition, affecting fetus or newborn noxious substance transmitted via breast milk or placenta 760.70 antimetabolics 760.78 transmission of chemical substance through the placenta 760.70 antimetabolics 760.78 Noxious substances transmitted through placenta or breast milk (affecting fetus or newborn) 760.70 acetretin 760.78 aminopterin 760.78 antimetabolic 760.78 atorvastatin 760.78 etretinate 760.78 fluvastatin 760.78 lovastatin 760.78 methotrexate 760.78 pravastatin 760.78 retinoic acid 760.78 simvastatin 760.78 statins 760.78 vitamin A 760.78 Transmission of chemical substances through the placenta (affecting fetus or newborn) 760.70 antimetabolics 760.78